vs
Side-by-side financial comparison of Confluent, Inc. (CFLT) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
Confluent, Inc. is the larger business by last-quarter revenue ($314.8M vs $168.4M, roughly 1.9× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 20.5%). Over the past eight quarters, Confluent, Inc.'s revenue compounded faster (20.4% CAGR vs 10.6%).
Confluent, Inc. is an American technology company headquartered in Mountain View, California. Confluent was founded by Jay Kreps, Jun Rao and Neha Narkhede on September 23, 2014, in order to commercialize an open-source streaming platform Apache Kafka, created by the same founders while working at LinkedIn in 2008 as a B2B infrastructure company. Confluent's products are the Confluent Cloud, Confluent Platform, Connectors, Apache Flink, Stream Governance and Confluent Hub.
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
CFLT vs ESPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $314.8M | $168.4M |
| Net Profit | $-79.2M | — |
| Gross Margin | 74.7% | — |
| Operating Margin | -31.5% | 50.6% |
| Net Margin | -25.2% | — |
| Revenue YoY | 20.5% | 143.7% |
| Net Profit YoY | 10.0% | — |
| EPS (diluted) | $-0.23 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $314.8M | $168.4M | ||
| Q3 25 | $298.5M | $87.3M | ||
| Q2 25 | $282.3M | $82.4M | ||
| Q1 25 | $271.1M | $65.0M | ||
| Q4 24 | $261.2M | $69.1M | ||
| Q3 24 | $250.2M | $51.6M | ||
| Q2 24 | $235.0M | $73.8M | ||
| Q1 24 | $217.2M | $137.7M |
| Q4 25 | $-79.2M | — | ||
| Q3 25 | $-66.5M | $-31.3M | ||
| Q2 25 | $-82.0M | $-12.7M | ||
| Q1 25 | $-67.6M | $-40.5M | ||
| Q4 24 | $-88.1M | — | ||
| Q3 24 | $-74.1M | $-29.5M | ||
| Q2 24 | $-89.9M | $-61.9M | ||
| Q1 24 | $-93.0M | $61.0M |
| Q4 25 | 74.7% | — | ||
| Q3 25 | 74.2% | — | ||
| Q2 25 | 73.7% | — | ||
| Q1 25 | 74.5% | — | ||
| Q4 24 | 74.1% | — | ||
| Q3 24 | 74.5% | — | ||
| Q2 24 | 72.3% | — | ||
| Q1 24 | 71.8% | — |
| Q4 25 | -31.5% | 50.6% | ||
| Q3 25 | -27.9% | -11.4% | ||
| Q2 25 | -34.2% | 8.6% | ||
| Q1 25 | -37.3% | -34.0% | ||
| Q4 24 | -40.5% | -6.4% | ||
| Q3 24 | -37.4% | -31.0% | ||
| Q2 24 | -46.1% | 3.5% | ||
| Q1 24 | -51.3% | 52.5% |
| Q4 25 | -25.2% | — | ||
| Q3 25 | -22.3% | -35.9% | ||
| Q2 25 | -29.0% | -15.4% | ||
| Q1 25 | -24.9% | -62.2% | ||
| Q4 24 | -33.7% | — | ||
| Q3 24 | -29.6% | -57.2% | ||
| Q2 24 | -38.3% | -83.9% | ||
| Q1 24 | -42.8% | 44.3% |
| Q4 25 | $-0.23 | $0.32 | ||
| Q3 25 | $-0.19 | $-0.16 | ||
| Q2 25 | $-0.24 | $-0.06 | ||
| Q1 25 | $-0.20 | $-0.21 | ||
| Q4 24 | $-0.26 | $-0.14 | ||
| Q3 24 | $-0.23 | $-0.15 | ||
| Q2 24 | $-0.28 | $-0.33 | ||
| Q1 24 | $-0.30 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $347.2M | $167.9M |
| Total DebtLower is stronger | $1.1B | — |
| Stockholders' EquityBook value | $1.2B | $-302.0M |
| Total Assets | $3.0B | $465.9M |
| Debt / EquityLower = less leverage | 0.94× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $347.2M | $167.9M | ||
| Q3 25 | $298.5M | $92.4M | ||
| Q2 25 | $295.6M | $86.1M | ||
| Q1 25 | $278.6M | $114.6M | ||
| Q4 24 | $386.0M | $144.8M | ||
| Q3 24 | $322.6M | $144.7M | ||
| Q2 24 | $311.3M | $189.3M | ||
| Q1 24 | $336.4M | $226.6M |
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — |
| Q4 25 | $1.2B | $-302.0M | ||
| Q3 25 | $1.1B | $-451.4M | ||
| Q2 25 | $1.1B | $-433.5M | ||
| Q1 25 | $1.0B | $-426.2M | ||
| Q4 24 | $961.2M | $-388.7M | ||
| Q3 24 | $934.3M | $-370.2M | ||
| Q2 24 | $873.9M | $-344.2M | ||
| Q1 24 | $845.2M | $-294.3M |
| Q4 25 | $3.0B | $465.9M | ||
| Q3 25 | $2.9B | $364.0M | ||
| Q2 25 | $2.8B | $347.1M | ||
| Q1 25 | $2.7B | $324.0M | ||
| Q4 24 | $2.7B | $343.8M | ||
| Q3 24 | $2.6B | $314.1M | ||
| Q2 24 | $2.5B | $352.3M | ||
| Q1 24 | $2.4B | $373.1M |
| Q4 25 | 0.94× | — | ||
| Q3 25 | 0.98× | — | ||
| Q2 25 | 1.03× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 1.17× | — | ||
| Q2 24 | 1.25× | — | ||
| Q1 24 | 1.29× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $42.1M | $45.2M |
| Free Cash FlowOCF − Capex | $41.7M | — |
| FCF MarginFCF / Revenue | 13.2% | — |
| Capex IntensityCapex / Revenue | 0.1% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $60.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $42.1M | $45.2M | ||
| Q3 25 | $30.8M | $-4.3M | ||
| Q2 25 | $18.1M | $-31.4M | ||
| Q1 25 | $-26.8M | $-22.6M | ||
| Q4 24 | $35.2M | $-35.0M | ||
| Q3 24 | $15.6M | $-35.3M | ||
| Q2 24 | $8.6M | $-7.2M | ||
| Q1 24 | $-26.0M | $53.8M |
| Q4 25 | $41.7M | — | ||
| Q3 25 | $30.0M | — | ||
| Q2 25 | $17.2M | — | ||
| Q1 25 | $-28.2M | — | ||
| Q4 24 | $34.5M | — | ||
| Q3 24 | $15.0M | $-35.5M | ||
| Q2 24 | $7.5M | $-7.3M | ||
| Q1 24 | $-26.1M | $53.8M |
| Q4 25 | 13.2% | — | ||
| Q3 25 | 10.0% | — | ||
| Q2 25 | 6.1% | — | ||
| Q1 25 | -10.4% | — | ||
| Q4 24 | 13.2% | — | ||
| Q3 24 | 6.0% | -68.7% | ||
| Q2 24 | 3.2% | -9.9% | ||
| Q1 24 | -12.0% | 39.0% |
| Q4 25 | 0.1% | 0.0% | ||
| Q3 25 | 0.3% | 0.0% | ||
| Q2 25 | 0.3% | 0.0% | ||
| Q1 25 | 0.5% | 0.0% | ||
| Q4 24 | 0.3% | 0.0% | ||
| Q3 24 | 0.2% | 0.3% | ||
| Q2 24 | 0.5% | 0.1% | ||
| Q1 24 | 0.1% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CFLT
| Confluent Cloud | $169.4M | 54% |
| Post Contract Customer Support | $93.8M | 30% |
| License | $38.4M | 12% |
| Services | $13.2M | 4% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
